Wingless modulates activator protein-1-mediated tumor invasion

Shiping Zhang1,2, Xiaowei Guo1, Honggui Wu1

  • 1Institute of Intervention Vessel, Shanghai 10th People's Hospital, Shanghai Key Laboratory of Signaling and Diseases Research, School of Life Science and Technology, Tongji University, 1239 Siping Road, Shanghai, 200092, China.

Oncogene
|January 27, 2019
PubMed

Insights

Wingless (Wg) signaling drives tumor cell invasion by disrupting cell polarity and promoting epithelial-mesenchymal transition (EMT). This conserved mechanism links JNK and Wnt pathways, offering new therapeutic targets for metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Metastasis is a leading cause of cancer mortality, yet the role of the Wnt/β-catenin pathway in tumor invasion is debated.
  • Understanding the mechanisms of tumor metastasis is crucial for developing effective cancer treatments.

Purpose of the Study:

  • To investigate the role of the Wingless (Wg) pathway in regulating tumor invasion using Drosophila models.
  • To elucidate the molecular mechanisms connecting cell polarity, JNK signaling, and Wnt pathway activation in tumor progression.

Main Methods:

  • Utilized established Drosophila tumor models to study Wg pathway function in tumor invasion.
  • Investigated the role of JNK signaling and the transcription factor AP-1 in regulating Wg expression.
  • Confirmed the conservation of AP-1 mediated WNT transcriptional activation in human cancer cells.

Main Results:

  • Wg signaling is essential for cell polarity disruption-induced cell migration and epithelial-mesenchymal transition (EMT)-like changes.
  • Reduced Wg signaling inhibited tumor invasion in Drosophila models.
  • JNK signaling activation by cell polarity disruption upregulates Wg expression via AP-1 binding to a conserved site in the wg gene.
  • Cooperation between Arm and RasV12 was sufficient to induce tumor invasion.

Conclusions:

  • The Wnt/β-catenin pathway plays a pro-invasive role in cancer metastasis.
  • A conserved mechanism links JNK signaling and Wnt pathway activation through AP-1, promoting tumor invasion.
  • This pathway provides a potential target for anti-metastasis therapies.

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
902
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.4K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.8K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K